The Monitor

February 2010
From the molecular level, preclinical testing, and personalized medicine through to a vision for the future, the themed articles in this issue provide insight into the breadth and depth of the creativity in drug development occurring in the here and now across the clinical research enterprise. The authors call upon their unique perspectives to present a vision of better treatment based on solid scientific evidence that is learned at the bench and applied at the bedside.